Sclerostin antibody prevents particle-induced implant loosening by stimulating bone formation and inhibiting bone resorption in a rat model

Arthritis and Rheumatism

Volumn 64, Issue 12, 2012, Pages 4012-4020

  Liu, Shuo ^a,b   Virdi, Amarjit S ^a,b   Sena, Kotaro ^a,b   Sumner, Dale R ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; POLYETHYLENE; PROTEIN ANTIBODY; SCLEROSTIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; IMMUNOTHERAPY; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS FIXATION; PROSTHESIS LOOSENING; RAT;

ANIMALS; ANTIBODIES; BONE MORPHOGENETIC PROTEINS; BONE RESORPTION; FEMUR; GENETIC MARKERS; MALE; MODELS, ANIMAL; OSTEOGENESIS; POLYETHYLENE; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TITANIUM; TOMOGRAPHY, X-RAY COMPUTED; WNT PROTEINS;

EID: 84870317669     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37697     Document Type: Article

References (50)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M,. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89: 780-5. (Pubitemid 46564282)
2. Willert HG, Bertram H, Buchhorn GH,. Osteolysis in alloarthroplasty of the hip: the role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 1990; 258: 95-107.
3. Glant TT, Jacobs JJ, Molnar G, Shanbhag AS, Valyon M, Galante JO,. Bone resorption activity of particulate-stimulated macrophages. J Bone Miner Res 1993; 8: 1071-9. (Pubitemid 23261100)
4. Millett PJ, Allen MJ, Bostrom MP,. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 2002; 84-A: 236-49. (Pubitemid 37127485)
5. Iwase M, Kim KJ, Kobayashi Y, Itoh M, Itoh T,. A novel bisphosphonate inhibits inflammatory bone resorption in a rat osteolysis model with continuous infusion of polyethylene particles. J Orthop Res 2002; 20: 499-505. (Pubitemid 34461008)
6. Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL, et al. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 2005; 23: 501-10. (Pubitemid 40631319)
7. Zhang T, Yu H, Gong W, Zhang L, Jia T, Wooley PH, et al. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Biomaterials 2009; 30: 6102-8.
8. Wilkinson JM, Little DG,. Bisphosphonates in orthopedic applications. Bone 2011; 49: 95-102.
9. Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, Kronenberg HM, et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008; 135: 3801-11.
10. Van Bezooijen RL, Roelen BA, Visser A, Wee-Pals L, de Wilt E, Karperien M, et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 2004; 199: 805-14. (Pubitemid 38375200)
11. Li X, Ominsky M, Niu Q, Sun N, Daugherty B, D'Agostin D, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 2008; 23: 860-9. (Pubitemid 351768804)
12. Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 2009; 24: 578-88.
13. Ominsky MS, Li C, Li X, Tan HL, Lee E, Barrero M, et al. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of non-fractured bones. J Bone Miner Res 2011; 26: 1012-21.
14. Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P,. Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res 2010; 25: 2412-8.
15. Virdi AS, Liu M, Sena K, Maletich J, McNulty M, Ke HZ, et al. Sclerostin antibody increases bone volume and enhances implant fixation in a rat model. J Bone Joint Surg Am 2012; 94: 1670-80.
16. Tian X, Setterberg RB, Li X, Paszty C, Ke HZ, Jee WS,. Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats. Bone 2010; 47: 529-33.
17. Liu S, Virdi AS, Sena K, Hughes WF, Sumner DR,. Bone turnover markers correlate with implant fixation in a rat model using LPS doped particles to induce implant loosening. J Biomed Mater Res A 2012; 100: 918-28.
18. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R,. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010; 25: 1468-86.
19. Liu S, Broucek J, Virdi AS, Sumner DR,. Limitations of using micro-computed tomography to predict bone-implant contact and mechanical fixation. J Microsc 2012; 245: 34-42.
20. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry standardization of nomenclature, symbols, and units. J Bone Miner Res 1987; 2: 595-610.
21. Thadani PJ, Waxman B, Sladek E, Barmada R, Gonzalez MH,. Inhibition of particulate debris-induced osteolysis by alendronate in a rat model. Orthopedics 2002; 25: 59-63. (Pubitemid 34092707)
22. Shanbhag AS, Hasselman CT, Rubash HE,. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997; 344: 33-43. (Pubitemid 27490634)
23. Von Knoch M, Wedemeyer C, Pingsmann A, von Knoch F, Hilken G, Sprecher C, et al. The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 2005; 26: 1803-8. (Pubitemid 39575322)
24. Wedemeyer C, von Knoch F, Pingsmann A, Hilken G, Sprecher C, Saxler G, et al. Stimulation of bone formation by zoledronic acid in particle-induced osteolysis. Biomaterials 2005; 26: 3719-25. (Pubitemid 40038167)
25. Von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Brankamp J, et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 2005; 75: 288-94. (Pubitemid 41463897)
26. Ulrich-Vinther M, Carmody EE, Goater JJ, Soballe K, O'Keefe RJ, Schwarz EM,. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002; 84-A: 1405-12. (Pubitemid 35407586)
27. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM,. Effect of anti-tumor necrosis factor-α gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001; 83-A: 1789-97. (Pubitemid 33134432)
28. Dong L, Wang R, Zhu YA, Wang C, Diao H, Zhang C, et al. Antisense oligonucleotide targeting TNF-α can suppress Co-Cr-Mo particle-induced osteolysis. J Orthop Res 2008; 28: 1114-20.
29. Goodman S, Trindade M, Ma T, Lee M, Wang N, Ikenou T, et al. Modulation of bone ingrowth and tissue differentiation by local infusion of interleukin-10 in the presence of ultra-high molecular weight polyethylene (UHMWPE) wear particles. J Biomed Mater Res A 2003; 65A: 43-50. (Pubitemid 37517284)
30. Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ,. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 2002; 46: 1298-308. (Pubitemid 34525839)
31. Yang SY, Wu B, Mayton L, Mukherjee P, Robbins PD, Evans CH, et al. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 2004; 11: 483-91. (Pubitemid 38313169)
32. Darowish M, Rahman R, Li P, Bukata SV, Gelinas J, Huang W, et al. Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation. Bone 2009; 45: 661-8.
33. Markel DC, Zhang R, Shi T, Hawkins M, Ren W,. Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis. Inflamm Res 2009; 58: 413-21.
34. Ma T, Nelson ER, Mawatari T, Oh KJ, Larsen DM, Smith RL, et al. Effects of local infusion of OP-1 on particle-induced and NSAID-induced inhibition of bone ingrowth in vivo. J Biomed Mater Res A 2006; 79: 740-6. (Pubitemid 44845190)
35. Von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Henschke F, et al. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 2005; 26: 3549-55. (Pubitemid 40038149)
36. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, Bylski D, von Knoch F, et al. Polyethylene particle-induced bone resorption in α-calcitonin gene-related peptide-deficient mice. J Bone Miner Res 2007; 22: 1011-9. (Pubitemid 351339723)
37. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, von Knoch F, Hilken G, et al. Polyethylene particle-induced bone resorption in substance P-deficient mice. Calcif Tissue Int 2007; 80: 268-74. (Pubitemid 46675248)
38. Landgraeber S, Jaeckel S, Loer F, Wedemeyer C, Hilken G, Canbay A, et al. Pan-caspase inhibition suppresses polyethylene particle-induced osteolysis. Apoptosis 2009; 14: 173-81.
39. Smith RA, Maghsoodpoour A, Hallab NJ,. In vivo response to cross-linked polyethylene and polycarbonate-urethane particles. J Biomed Mater Res A 2010; 93: 227-34.
40. Vermes C, Roebuck KA, Chandrasekaran R, Dobai JG, Jacobs JJ, Glant TT,. Particulate wear debris activates protein tyrosine kinases and nuclear factor κB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 2000; 15: 1756-65. (Pubitemid 30666229)
41. Sacomen D, Smith RL, Song Y, Fornasier V, Goodman SB,. Effects of polyethylene particles on tissue surrounding knee arthroplasties in rabbits. J Biomed Mater Res 1998; 43: 123-30. (Pubitemid 28246964)
42. Atkins GJ, Welldon KJ, Holding CA, Haynes DR, Howie DW, Findlay DM,. The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials 2009; 30: 3672-81.
43. Kim KJ, Kobayashi Y, Itoh T,. Osteolysis model with continuous infusion of polyethylene particles. Clin Orthop Relat Res 1998; 352: 46-52. (Pubitemid 28326283)
44. Bobyn JD, Jacobs JJ, Tanzer M, Urban RM, Aribindi R, Sumner DR, et al. The susceptibility of smooth implant surfaces to periimplant fibrosis and migration of polyethylene wear debris. Clin Orthop Relat Res 1995; 311: 21-39.
45. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neill DA, Harris WH,. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 1983; 65: 575-84. (Pubitemid 13107113)
46. Choi Y, Arron JR, Townsend MJ,. Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol 2009; 5: 543-8.
47. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFα induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 2009; 24: 1434-49.
48. Silvestrini G, Ballanti P, Sebastiani M, Leopizzi M, Di Vito M, Bonucci E,. OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST. J Mol Histol 2008; 39: 237-42. (Pubitemid 351422033)
49. Lichtenstein GR,. Evaluation of bone mineral density in inflammatory bowel disease: current safety focus. Am J Gastroenterol 2003; 98: S24-30. (Pubitemid 38044604)
50. Eddleston A, Marenzana M, Moore AR, Stephens P, Muzylak M, Marshall D, et al. A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis. J Bone Miner Res 2009; 24: 1662-71.